Anti-abortion groups in the USA are intensifying pressure on the Food and Drug Administration to restrict access to the abortion pill mifepristone following a significant court ruling in Louisiana.Attorney General Liz Murrill initiated the lawsuit, arguing that federal rules allowing telehealth prescriptions and mail distribution undermine state-level abortion bans in 13 regions.US District Judge David Joseph, a Trump appointee, recently acknowledged that the state has a strong legal argument but declined to issue an immediate injunction against the medication.Health and Human Services Secretary
Robert F. Kennedy Jr. confirmed that the administration is conducting an expedited safety review at President
Donald Trump's request.